Amyloid precursor protein (APP) regulates synaptic structure and function.
- Authors
- Tyan, Sheue-Houy; Shih, Ann Yu-Jung; Walsh, Jessica J; Maruyama, Hiroko; Sarsoza, Floyd; Ku, Lawrence; Eggert, Simone; Hof, Patrick R; Koo, Edward H; Dickstein, Dara L
- Year
- 2012
- Journal
- Molecular and cellular neurosciences
- PMID
- 22884903
- DOI
- 10.1016/j.mcn.2012.07.009
- PMCID
- PMC3538857
The amyloid precursor protein (APP) plays a critical role in Alzheimer's disease (AD) pathogenesis. APP is proteolytically cleaved by β- and γ-secretases to generate the amyloid β-protein (Aβ), the core protein component of senile plaques in AD. It is also cleaved by α-secretase to release the large soluble APP (sAPP) luminal domain that has been shown to exhibit trophic properties. Increasing evidence points to the development of synaptic deficits and dendritic spine loss prior to deposition of amyloid in transgenic mouse models that overexpress APP and Aβ peptides. The consequence of loss of APP, however, is unsettled. In this study, we investigated whether APP itself plays a role in regulating synaptic structure and function using an APP knock-out (APP-/-) mouse model. We examined dendritic spines in primary cultures of hippocampal neurons and CA1 neurons of hippocampus from APP-/- mice. In the cultured neurons, there was a significant decrease (~35%) in spine density in neurons derived from APP-/- mice compared to littermate control neurons that were partially restored with sAPPα-conditioned medium. In APP-/- mice in vivo, spine numbers were also significantly reduced but by a smaller magnitude (~15%). Furthermore, apical dendritic length and dendritic arborization were markedly diminished in hippocampal neurons. These abnormalities in neuronal morphology were accompanied by reduction in long-term potentiation. Strikingly, all these changes in vivo were only seen in mice that were 12-15 months in age but not in younger animals. We propose that APP, specifically sAPP, is necessary for the maintenance of dendritic integrity in the hippocampus in an age-associated manner. Finally, these age-related changes may contribute to AD pathology independent of Aβ-mediated synaptic toxicity.
APP−/− hippocampal neurons show a decrease in spine number. (A) Representative images of primary hippocampal neurons expressing eGFP. Top: APP+/− (left) and APP−/− (Holcomb et al., 1998) neurons were from the same parental interbreeding of APP mice. The images were presented in grey and inverted color. Panels at the bottom of each image show high-magnification renderings of dendritic segments. The dendritic images were taken with 0.3-μm step z-section and then stacked with maximum projection. Scale bar: 150 μm (top) and 5 μm (bottom). (B) Quantification of spine density. There was no difference in spine number between APP+/+ and APP+/− (p > 0.05). APP−/− neurons showed highly significant decrease in spine density compared to APP+/+ or APP+/− neurons (**, p < 0.01 and ***, p < 0.001). Data are expressed as mean ± SEM and tested using a one-way ANOVA with Tukey’s post-hoc test.
3-Dimensional reconstructions of CA1 neurons. (A-D) Representative examples of 3-dimensional reconstructions of neurons and the corresponding apical dendrograms (arrow indicates the apical dendrite). Dendrograms of CA1 pyramidal layer neurons in 13 months old APP+/− and APP−/− mice (A and B); and in young APP+/− and APP−/− mice (C and D; 2-4 months old). (E) and (F) Dendrogram and quantification of dendritic length of CA1 neurons in APP−/− mice. Thirteen month-old APP−/− exhibited a significant decrease in apical length compared to APP+/−, whereas young APP−/− mice showed no significant difference in apical dendritic length compared to APP+/− mice (E). There is no difference in basal dendritic length among APP+/− and APP−/− mice of both age groups (F). Data are expressed as mean ± SEM; asterisks indicate significant differences between groups (*, p < 0.05; unpaired t-test).
Quantification of spine density in APP animal. (A) Representative dendrite images after 3-dimensional deconvolution and processing with NeuronStudio software (see methods). Scale bars: 5 μm. (B) The spine density was decreased (left) ~15% in old APP−/− mice compared to their littermate controls (APP+/−). Young APP−/− mice showed no significant difference in spine density compared to APP+/− mice. The young mice were 2-4 months old. Data are expressed as means ± SEM; asterisks indicate significant differences between groups (**, p < 0.01; unpaired t-test).
APP−/− mice showed impaired electrical properties in acute hippocampal slices of old APP−/− mice. (A) 12-15 months old APP−/− mice (closed triangles) showed impairment in LTP but not in APP+/− mice (open circle). (B) Young APP−/− mice showed normal LTP as did their littermate controls. fEPSPs were recorded in stratum radiatum (dendritic area) of the CA1 region following stimulation of the Schaffer collateral pathway. LTP were induced with 4 tetanus stimulation delivered at 20-s intervals, each at 100 Hz for 1 s. (C) and (D) Basal synaptic transmission was assayed by measuring fEPSPs within the stratum radiatum of the CA1 region of the hippocampus evoked by a bipolar electrode placed at the CA3–CA1 border. For each level of stimulation, the maximum amplitude of the presynaptic fiber volley (FV; arrow) and the initial slope of the fEPSP were measured (see also supplemental Fig. 1). Scatter plot of the fEPSP slope versus fiber volley of every recording in old APP−/− mice (closed triangles, black line; n = 24 slices, 9 animals) and APP+/− mice (16 slices, 7 animals; open circle, dash line), fit by linear regression. There is no significant difference in basal transmission among APP+/− and APP−/− mice in both age groups. (E) and (F) Paired-pulse facilitation at the Schaffer collateral CA1 synapse was measured by dividing the amplitude of the second fEPSP by the amplitude of the first elicited by a pair of two 50-ms spaced stimuli. No significant change in PPF ratio was observed in both age groups between APP+/− and APP−/− mice.
APP deficient effects on spines are prevented by adding conditioned medium (CM) from APP wild type neurons (APP+/+ or APP+/−). (A) Representative culture APP−/− hippocampal neurons expressing eGFP: APP−/− neurons are shown at right and wild type CM-treated APP−/− neurons at left. Scale bars: 20 (top) and 5 (bottom) μm. Wild type CM was replaced with medium on the second day after plating the neurons. The medium was changed every other day. The bottom of each image shows high-magnification micrographs of dendrites. (B) The quantification of spine density. Wild types CM rescue the decrease in spine density of APP−/− neurons (*, p < 0.05; **, p < 0.01, unpaired t-test).
Soluble APPα but not soluble APPβ rescued partially deficits in dendritic spine number and morphology. (A) The scheme of soluble mouse APP (sAPPα and sAPPβ) and full length of mouse APP (APP). (B) left, 63G antibody (the polyclonal antibody against the middle region of APP) Western blot from medium of B103 cells transfected with either sAPPα ( lanes 1 and 4 from two of single clone), sAPPβ (lane 5) or mouse APP695 (APP) constructs (lane 3) and the non-transfected control (lane 2); Right: CT15 immunoblot from cell lysates of untransfected (lane 6), mouse APP-transfected (lane 7), sAPPα-transfected (lane 8) and sAPPβ-transfected B103 cells (lane 9). (c) Quantification of spine density. APP−/− neurons were treated with medium from either sAPPα-, sAPPβ- and vehicle-transfected B103 cells or from the conditioned medium of APP WT (APP+/+ or APP+/−) neurons (each treatment is indicated in the bar legend). The spine density was restored partially in sAPPα-treated APP−/− neurons compared to APP−/− neurons (*, p < 0.05, unpaired t-test). The sAPPβ-CM did not restore spine density in APP−/− neurons (p > 0.5, unpaired t-test).
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Stress-response pathways are altered in the hippocampus of chronic alcoholics. | 2013 | 23981442 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| APP as an innate injury-response molecule. | Olmsted ZT et al. | — | 2026 | → |
| sAPPα Inhibits Neurite Outgrowth in Primary Mouse Neurons via GABA B Receptor Subunit 1a. | Barber D et al. | — | 2026 | → |
| APP β-CTF triggers cell-autonomous synaptic toxicity independent of Aβ. | Luo M et al. | — | 2025 | → |
| Decoding hippocampal subfield and glial responses in ischemia using single-cell transcriptomics. | Kwak D et al. | — | 2025 | → |
| Genome-Wide Study of Diabetes Mellitus (Type 2)-Associated Genes in Homo sapiens (Human). | Shaukat R et al. | — | 2025 | → |
| Integrative analysis of proteomic and MRI data reveals protein associations with brain imaging features in Alzheimer's disease. | Afxenti S et al. | — | 2025 | → |
| Interrogating mediators of single-cell transcriptional changes in the acute damaged cerebral cortex: Insights into endothelial-astrocyte interactions. | de Jager C et al. | — | 2025 | → |
| Lipofuscin accumulation in aging and neurodegeneration: a potential "timebomb" overlooked in Alzheimer's disease. | Dougnon G et al. | — | 2025 | → |
| Recent advances in Alzheimer's disease therapy: clinical trials and literature review of novel enzyme inhibitors targeting amyloid precursor protein. | Antony D et al. | — | 2025 | → |
| Remote spatial memory deficits in mouse models of neuropsychiatric disorders with immature dentate gyrus phenotype. | Shoji H et al. | — | 2025 | → |
| Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier. | Takeuchi LE et al. | — | 2025 | → |
| Alpha-lipoic acid alleviates cognitive deficits in transgenic APP23/PS45 mice through a mitophagy-mediated increase in ADAM10 α-secretase cleavage of APP. | Zhang J et al. | — | 2024 | → |
| Amyloid Precursor Protein: A Regulatory Hub in Alzheimer's Disease. | Chen J et al. | — | 2024 | → |
| CNTN4 modulates neural elongation through interplay with APP. | Bamford RA et al. | — | 2024 | → |
| Histone deacetylase-3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer's disease models. | Davis N et al. | — | 2024 | → |
| Lactate increases ADAM10 activity and reduces BACE1 activity in mouse brain. | Moberg I et al. | — | 2024 | → |
| Amyloid Precursor Protein (APP) Regulates Gliogenesis and Neurogenesis of Human Neural Stem Cells by Several Signaling Pathways. | Coronel R et al. | — | 2023 | → |
| Amyloid-β Protein Precursor Regulates Electrophysiological Properties in the Hippocampus via Altered Kv1.4 Expression and Function in Mice. | Li Y et al. | — | 2023 | → |
| APP family member dimeric complexes are formed predominantly in synaptic compartments. | Schilling S et al. | — | 2023 | → |
| APPsα rescues CDK5 and GSK3β dysregulation and restores normal spine density in Tau transgenic mice. | Baltissen D et al. | — | 2023 | → |
| Association of overexpressed carboxyl-terminal amyloid precursor protein in brains with altered glucose metabolism and liver toxicity. | Hong S et al. | — | 2023 | → |
| Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway Model. | Hampel H et al. | — | 2023 | → |
| Ginsenoside ompound K reduces neuronal damage and improves neuronal synaptic dysfunction by targeting Aβ. | Li N et al. | — | 2023 | → |
| „APP family member dimeric complexes are formed predominantly in synaptic compartments“ | Schilling S et al. | — | 2022 | — |
| APPsα Rescues Tau-Induced Synaptic Pathology. | Bold CS et al. | — | 2022 | → |
| Effects of multi-mode physical stimulation on APP/PS1 Alzheimer's disease model mice. | Liu S et al. | — | 2022 | → |
| Ferroptosis participates in neuron damage in experimental cerebral malaria and is partially induced by activated CD8<sup>+</sup> T cells. | Liang J et al. | — | 2022 | → |
| Identification of the probable structure of the sAPPα-GABA<sub>B</sub>R1a complex and theoretical solutions for such cases. | Yang H et al. | — | 2022 | → |
| Improved NMDA Receptor Activation by the Secreted Amyloid-Protein Precursor-α in Healthy Aging: A Role for D-Serine? | Billard JM et al. | — | 2022 | → |
| Lack of APLP1 leads to subtle alterations in neuronal morphology but does not affect learning and memory. | Erdinger S et al. | — | 2022 | → |
| Synaptic dysfunction in early phases of Alzheimer's Disease. | Pelucchi S et al. | — | 2022 | → |
| Synaptogenic effect of <i>APP</i>-Swedish mutation in familial Alzheimer's disease. | Zhou B et al. | — | 2022 | → |
| The Autism Spectrum Disorder-Associated Bacterial Metabolite <i>p</i>-Cresol Derails the Neuroimmune Response of Microglial Cells Partially via Reduction of ADAM17 and ADAM10. | Zheng Y et al. | — | 2022 | → |
| Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies. | Slater C et al. | — | 2021 | → |
| Amyloid Beta-Mediated Changes in Synaptic Function and Spine Number of Neocortical Neurons Depend on NMDA Receptors. | Back MK et al. | — | 2021 | → |
| Amyloid-Beta Mediates Homeostatic Synaptic Plasticity. | Galanis C et al. | — | 2021 | → |
| APP Binds to the EGFR Ligands HB-EGF and EGF, Acting Synergistically with EGF to Promote ERK Signaling and Neuritogenesis. | da Rocha JF et al. | — | 2021 | → |
| Chronic Low Dose Neutron Exposure Results in Altered Neurotransmission Properties of the Hippocampus-Prefrontal Cortex Axis in Both Mice and Rats. | Krishnan B et al. | — | 2021 | → |
| Comprehensive analysis of O-glycosylation of amyloid precursor protein (APP) using targeted and multi-fragmentation MS strategy. | Shi J et al. | — | 2021 | → |
| Dysfunction in nonsense-mediated decay, protein homeostasis, mitochondrial function, and brain connectivity in ALS-FUS mice with cognitive deficits. | Ho WY et al. | — | 2021 | → |
| Fe65: A Scaffolding Protein of Actin Regulators. | Augustin V et al. | — | 2021 | → |
| Huntingtin and the Synapse. | Barron JC et al. | — | 2021 | → |
| Inflammation and Alzheimer's Disease: Mechanisms and Therapeutic Implications by Natural Products. | Rather MA et al. | — | 2021 | → |
| Molecular mechanism of secreted amyloid-β precursor protein in binding and modulating GABA<sub>B</sub>R1a. | Feng M et al. | — | 2021 | → |
| Protective Role of a Donepezil-Huprine Hybrid against the β-Amyloid (1-42) Effect on Human Erythrocytes. | Zambrano P et al. | — | 2021 | → |
| Rapid evolution of mammalian APLP1 as a synaptic adhesion molecule. | Onodera W et al. | — | 2021 | → |
| The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer's Disease Pathogenesis. | Jasiecki J et al. | — | 2021 | → |
| Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery? | Mullane K et al. | — | 2020 | → |
| Amyloid, APP, and Electrical Activity of the Brain. | Hefter D et al. | — | 2020 | → |
| Amyloid Precursor Protein (APP) Controls the Expression of the Transcriptional Activator Neuronal PAS Domain Protein 4 (NPAS4) and Synaptic GABA Release. | Opsomer R et al. | — | 2020 | → |
| APP Family Regulates Neuronal Excitability and Synaptic Plasticity but Not Neuronal Survival. | Lee SH et al. | — | 2020 | → |
| Caspase Activation and Caspase-Mediated Cleavage of APP Is Associated with Amyloid β-Protein-Induced Synapse Loss in Alzheimer's Disease. | Park G et al. | — | 2020 | → |
| Disentangling the Amyloid Pathways: A Mechanistic Approach to Etiology. | Malmberg M et al. | — | 2020 | → |
| Hebbian and Homeostatic Synaptic Plasticity-Do Alterations of One Reflect Enhancement of the Other? | Galanis C et al. | — | 2020 | → |
| Lack of APP and APLP2 in GABAergic Forebrain Neurons Impairs Synaptic Plasticity and Cognition. | Mehr A et al. | — | 2020 | → |
| PhIP exposure in rodents produces neuropathology potentially relevant to Alzheimer's disease. | Syeda T et al. | — | 2020 | → |
| Spatiotemporal relationship between subthreshold amyloid accumulation and aerobic glycolysis in the human brain. | Goyal MS et al. | — | 2020 | → |
| The Interaction Between Contactin and Amyloid Precursor Protein and Its Role in Alzheimer's Disease. | Bamford RA et al. | — | 2020 | → |
| Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. | Kulas JA et al. | — | 2019 | → |
| Amyloid Precursor Protein (APP) and GABAergic Neurotransmission. | Tang BL | — | 2019 | → |
| APP depletion alters selective pre- and post-synaptic proteins. | Martinsson I et al. | — | 2019 | → |
| Defining the binding interface of Amyloid Precursor Protein (APP) and Contactin3 (CNTN3) by site-directed mutagenesis. | Peng X et al. | — | 2019 | → |
| FUS-mediated dysregulation of Sema5a, an autism-related gene, in FUS mice with hippocampus-dependent cognitive deficits. | Ho WY et al. | — | 2019 | → |
| Knockout of Amyloid β Protein Precursor (APP) Expression Alters Synaptogenesis, Neurite Branching and Axonal Morphology of Hippocampal Neurons. | Southam KA et al. | — | 2019 | → |
| Liver Dysfunction as a Novel Player in Alzheimer's Progression: Looking Outside the Brain. | Estrada LD et al. | — | 2019 | → |
| Neuromodulatory Action of Picomolar Extracellular Aβ42 Oligomers on Presynaptic and Postsynaptic Mechanisms Underlying Synaptic Function and Memory. | Gulisano W et al. | — | 2019 | → |
| Neuronal and Glial Differentiation of Human Neural Stem Cells Is Regulated by Amyloid Precursor Protein (APP) Levels. | Coronel R et al. | — | 2019 | → |
| Physiological and pathological effects of amyloid-β species in neural stem cell biology. | Bernabeu-Zornoza A et al. | — | 2019 | → |
| Physiological effects of amyloid precursor protein and its derivatives on neural stem cell biology and signaling pathways involved. | Coronel R et al. | — | 2019 | → |
| Regulation of Neurotransmitter Release by Amyloid Precursor Protein Through Synapsin Phosphorylation. | Liu A et al. | — | 2019 | → |
| Secreted amyloid-β precursor protein functions as a GABA<sub>B</sub>R1a ligand to modulate synaptic transmission. | Rice HC et al. | — | 2019 | → |
| The ALS-FTD-linked gene product, C9orf72, regulates neuronal morphogenesis via autophagy. | Ho WY et al. | — | 2019 | → |
| The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis? | Dourlen P et al. | — | 2019 | → |
| Visualization of the Breakdown of the Axonal Transport Machinery: a Comparative Ultrastructural and Immunohistochemical Approach. | Rühling S et al. | — | 2019 | → |
| Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits. | Chatterjee S et al. | — | 2018 | → |
| APLP1 is endoproteolytically cleaved by γ-secretase without previous ectodomain shedding. | Schauenburg L et al. | — | 2018 | → |
| Dimerization leads to changes in APP (amyloid precursor protein) trafficking mediated by LRP1 and SorLA. | Eggert S et al. | — | 2018 | → |
| Distinct <i>in vivo</i> roles of secreted APP ectodomain variants APPsα and APPsβ in regulation of spine density, synaptic plasticity, and cognition. | Richter MC et al. | — | 2018 | → |
| Possible Clues for Brain Energy Translation via Endolysosomal Trafficking of APP-CTFs in Alzheimer's Disease. | Sivanesan S et al. | — | 2018 | → |
| Role of Amyloid Precursor Protein (APP) and Its Derivatives in the Biology and Cell Fate Specification of Neural Stem Cells. | Coronel R et al. | — | 2018 | → |
| Rosiglitazone rescues human neural stem cells from amyloid-beta induced ER stress via PPARγ dependent signaling. | Lin CH et al. | — | 2018 | → |
| ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer's disease. | Marcello E et al. | — | 2017 | → |
| Alpha-Linolenic Acid from Perilla frutescens var. japonica Oil Protects Aβ-Induced Cognitive Impairment through Regulation of APP Processing and Aβ Degradation. | Lee AY et al. | — | 2017 | → |
| Amyloid-precursor Like Proteins APLP1 and APLP2 Are Dispensable for Normal Development of the Neonatal Respiratory Network. | Han K et al. | — | 2017 | → |
| Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory. | Palmeri A et al. | — | 2017 | → |
| APLP1 Is a Synaptic Cell Adhesion Molecule, Supporting Maintenance of Dendritic Spines and Basal Synaptic Transmission. | Schilling S et al. | — | 2017 | → |
| APP-A Novel Player within the Presynaptic Active Zone Proteome. | Weingarten J et al. | — | 2017 | → |
| APP Deletion Accounts for Age-Dependent Changes in the Bioenergetic Metabolism and in Hyperphosphorylated CaMKII at Stimulated Hippocampal Presynaptic Active Zones. | Laßek M et al. | — | 2017 | → |
| APP Protein Family Signaling at the Synapse: Insights from Intracellular APP-Binding Proteins. | Guénette S et al. | — | 2017 | → |
| Cortical cells reveal APP as a new player in the regulation of GABAergic neurotransmission. | Doshina A et al. | — | 2017 | → |
| Direct evidence of amyloid precursor-like protein 1 <i>trans</i> interactions in cell-cell adhesion platforms investigated via fluorescence fluctuation spectroscopy. | Dunsing V et al. | — | 2017 | → |
| Functional Roles of the Interaction of APP and Lipoprotein Receptors. | Pohlkamp T et al. | — | 2017 | → |
| Human <i>APP</i> Gene Expression Alters Active Zone Distribution and Spontaneous Neurotransmitter Release at the <i>Drosophila</i> Larval Neuromuscular Junction. | Saburova EA et al. | — | 2017 | → |
| Not just amyloid: physiological functions of the amyloid precursor protein family. | Müller UC et al. | — | 2017 | → |
| Regulation of Alpha-Secretase ADAM10 <i>In vitro</i> and <i>In vivo</i>: Genetic, Epigenetic, and Protein-Based Mechanisms. | Endres K et al. | — | 2017 | → |
| Structure and Synaptic Function of Metal Binding to the Amyloid Precursor Protein and its Proteolytic Fragments. | Wild K et al. | — | 2017 | → |
| Synaptic dysfunction in Alzheimer's disease: From the role of amyloid β-peptide to the α-secretase ADAM10. | Musardo S et al. | — | 2017 | → |
| The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system. | Sosa LJ et al. | — | 2017 | → |
| Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα. | Mockett BG et al. | — | 2017 | → |
| The Role of APP in Structural Spine Plasticity. | Montagna E et al. | — | 2017 | → |
| YXQN Reduces Alzheimer's Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice. | Wang X et al. | — | 2017 | → |
| Amyloid precursor-like protein 1 (APLP1) exhibits stronger zinc-dependent neuronal adhesion than amyloid precursor protein and APLP2. | Mayer MC et al. | — | 2016 | → |
| Major Histocompatibility Complex class I proteins are critical for maintaining neuronal structural complexity in the aging brain. | Lazarczyk MJ et al. | — | 2016 | → |
| Novel Insights into the Physiological Function of the APP (Gene) Family and Its Proteolytic Fragments in Synaptic Plasticity. | Ludewig S et al. | — | 2016 | → |
| Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism. | Westmark CJ et al. | — | 2016 | → |
| Physiological role for amyloid precursor protein in adult experience-dependent plasticity. | Marik SA et al. | — | 2016 | → |
| Regulators of gene expression in Enteric Neural Crest Cells are putative Hirschsprung disease genes. | Schriemer D et al. | — | 2016 | → |
| Subacute Changes in Cleavage Processing of Amyloid Precursor Protein and Tau following Penetrating Traumatic Brain Injury. | Cartagena CM et al. | — | 2016 | → |
| The Association of Amyloid-β Protein Precursor With α- and β-Secretases in Mouse Cerebral Cortex Synapses Is Altered in Early Alzheimer's Disease. | Pliássova A et al. | — | 2016 | → |
| Acute function of secreted amyloid precursor protein fragment APPsα in synaptic plasticity. | Hick M et al. | — | 2015 | → |
| Beta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD). | Zhao Y et al. | — | 2015 | → |
| Cellular functions of the amyloid precursor protein from development to dementia. | van der Kant R et al. | — | 2015 | → |
| Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome. | Pasciuto E et al. | — | 2015 | → |
| Evaluation of drug-induced neurotoxicity based on metabolomics, proteomics and electrical activity measurements in complementary CNS in vitro models. | Schultz L et al. | — | 2015 | → |
| Extract of Caragana sinica as a potential therapeutic option for increasing alpha-secretase gene expression. | Schuck F et al. | — | 2015 | → |
| Loss of F-box only protein 2 (Fbxo2) disrupts levels and localization of select NMDA receptor subunits, and promotes aberrant synaptic connectivity. | Atkin G et al. | — | 2015 | → |
| Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology. | Price KA et al. | — | 2014 | → |
| Amyloid precursor protein and neural development. | Nicolas M et al. | — | 2014 | → |
| Asynchronous evolutionary origins of Aβ and BACE1. | Moore DB et al. | — | 2014 | → |
| Beyond pathology: APP, brain development and Alzheimer's disease. | Soldano A et al. | — | 2014 | → |
| Comparative analysis of single and combined APP/APLP knockouts reveals reduced spine density in APP-KO mice that is prevented by APPsα expression. | Weyer SW et al. | — | 2014 | → |
| Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model. | Steele JW et al. | — | 2014 | → |
| F-box only protein 2 (Fbxo2) regulates amyloid precursor protein levels and processing. | Atkin G et al. | — | 2014 | → |
| Neurogenin 2 mediates amyloid-β precursor protein-stimulated neurogenesis. | Bolós M et al. | — | 2014 | → |
| Novel zinc-binding site in the E2 domain regulates amyloid precursor-like protein 1 (APLP1) oligomerization. | Mayer MC et al. | — | 2014 | → |
| RanBP9 overexpression accelerates loss of pre and postsynaptic proteins in the APΔE9 transgenic mouse brain. | Wang H et al. | — | 2014 | → |
| Shedding of APP limits its synaptogenic activity and cell adhesion properties. | Stahl R et al. | — | 2014 | → |
| Spatial and temporal characteristics of normal and perturbed vesicle transport. | Iacobucci GJ et al. | — | 2014 | → |
| The structure and function of actin cytoskeleton in mature glutamatergic dendritic spines. | Bellot A et al. | — | 2014 | → |
| From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein. | Octave JN et al. | — | 2013 | → |
| Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions. | Prox J et al. | — | 2013 | → |
| Redundancy and divergence in the amyloid precursor protein family. | Shariati SA et al. | — | 2013 | → |
| Soluble alpha-APP (sAPPalpha) regulates CDK5 expression and activity in neurons. | Hartl D et al. | — | 2013 | → |
| Stress-response pathways are altered in the hippocampus of chronic alcoholics. | McClintick JN et al. | — | 2013 | → |
| The amyloid precursor protein: a biochemical enigma in brain development, function and disease. | Nalivaeva NN et al. | — | 2013 | → |
| The impact of cholesterol, DHA, and sphingolipids on Alzheimer's disease. | Grimm MO et al. | — | 2013 | → |
| The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice. | Prior M et al. | — | 2013 | → |